Psychosocial Correlates of Trait Emotional Intelligence and Psychosomatic Symptoms Among Adolesce… (NCT07694908) | Clinical Trial Compass
Active — Not RecruitingNot Applicable
Psychosocial Correlates of Trait Emotional Intelligence and Psychosomatic Symptoms Among Adolescents Exposed to Bullying and the Effects of Mindfulness-Based Stress Reduction.
Pakistan44 participantsStarted 2026-02-01
Plain-language summary
This study examines the psychosocial correlates of trait emotional intelligence and psychosomatic symptoms among adolescents exposed to bullying and analyzes the effetiveness of Mindfulness Based Stress Reduction (MBSR) program through a randomized controlled trial.
The study is two phased, in which the Phase 1 includes a cross sectional correlational survey that was administered to 403 adolescents aged 14 to 18 years studying in secondary schools and colleges of Rawalpindi and Islamabad, Pakistan to analyze the relationships among childhood traumatic experiences, mindfulness, and level of bullying exposure with trait emotional intelligence and psychosomatic symptoms to identify eligible participants for Phase 2.
In Phase 2, about 44 adolescents meeting eligibility criteria were randomly assigned to either an intervention group that received the 8 week MBSR intervention (n=22) or waitlist control group (n=22). Pre and post assessments were done to examine changes in trait emotional intelligence and psychosomatic symptoms, following the mbsr intervention.
Who can participate
Age range
14 Years – 18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Adolescents aged 14 to 18 years currently enrolled in secondary school and colleges of Rawalpindi and Islamabad Pakistan.
* Score at or above 75th percentile on Multidimensional Peer Victimization Scale (MPVS-24) indicating significant bullying exposure.
* Score at or above 75th percentile on Pediatric ACEs and Related Life Events Screener (PEARLS) indicating Meaningful childhood trauma history.
* Score at or below 25th percentile on Mindful Attention Awareness Scale (MAAS) Indicating low dispositional mindfulness.
* Score at or below 25th percentile on Trait Emotional Intelligence Questionnaire Adolescent Short Form (TEIQue-ASF) indicating Impaired trait emotional intelligence.
* Demonstrate increased psychosomatic symptoms on DSM-5 Level 2 Somatic Symptom Scale for Children aged 11 to 17.
* Access to smartphone tablet or computer with stable Internet connection for online session participation.
* Voluntary assent from participant and written informed consent from parent or guardian.
Exclusion Criteria:
* Current diagnosis of severe Psychiatric disorder such as Psychotic disorder.
* Currently receiving psychotherapy or any structured psychological treatment.
* Currently taking psychiatric or Mental health medication.
* Currently practicing mindfulness related exercises such as meditation Yoga or breathing exercises.
* Diagnosed chronic physical illness.
* Diagnosed physical or learning Disability.
* Unwillingness to commit to attending all eight week…
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Trait Emotional Intelligence
Timeframe: Baseline pre intervention and 8 weeks post intervention